Brief: Aura Biosciences Reports Q3 2022 Results
10/11/2022 12:29
Nov 10 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
* BELIEVES ITS CURRENT CASH AND CASH EQUIVALENTS AND
MARKETABLE
SECURITIES ARE SUFFICIENT TO FUND ITS OPERATIONS INTO 2024
* QTRLY LOSS PER SHARE $0.54
* Q3 EARNINGS PER SHARE VIEW $-0.51 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw716wxka
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs